Recent

% | $
Quotes you view appear here for quick access.

Array BioPharma Inc. Message Board

flannelhead69 4 posts  |  Last Activity: Apr 18, 2016 12:37 AM Member since: Mar 16, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • flannelhead69 flannelhead69 Apr 18, 2016 12:37 AM Flag

    If you copy and paste the quote in google, you see it's a quote on Janssen's website and it refers to all their drugs, not any specific one. Nothing to get excited about.

  • Reply to

    ARRY is invested in LOXO

    by slumdawg2011 Apr 17, 2016 6:09 PM
    flannelhead69 flannelhead69 Apr 18, 2016 12:09 AM Flag

    Per the 10K, ARRY was awarded a number of shares of preferred stock from Loxo equal to 19.9% interest in Loxo for the licensing rights to Loxo-101. When Loxo went public, those preferred shares were converted to 1.6 million common shares and promptly sold by ARRY for $20.8 million. So basically, ARRY got $21 million for their equity position, they receive $6-7 million a year from Loxo to pay for FTEs related to drug development, they'll get milestones in the single-digit millions and should Loxo bring Loxo-101 to market, ARRY will receive mid-single-digit royalties. Not a good deal.

  • Reply to

    loxo had news today

    by buyoutmoney175 Apr 11, 2016 11:29 PM
    flannelhead69 flannelhead69 Apr 12, 2016 5:38 AM Flag

    Google "AstraZeneca and VentiRx team up for PDL1-oncology vax trial in ovarian cancer:"

  • Reply to

    loxo had news today

    by buyoutmoney175 Apr 11, 2016 11:29 PM
    flannelhead69 flannelhead69 Apr 12, 2016 12:10 AM Flag

    You're counting that as news? Go play in traffic and leave this message board to the grownups.

    On another note, I'd about given up on the drugs that ARRY partnered on with Aslan and VentiRX because of a lack of news. It was nice seeing VentiRX announce a combo trial involving ARRY's TLR and a big pharma company's checkpoint inhibitor last week. Also very cool to see all the updates on the Aslan website and check out the five combo trials they're doing with ARRY's ASLAN001.

    Sentiment: Hold

ARRY
3.56+0.07(+2.01%)Jun 30 4:00 PMEDT